Chongkundang to develop novel production process of Tamiflu.

Published: 2005-12-05 06:56:00
Updated: 2005-12-05 06:56:00
Chongkundang announced on Nov. 30 that the company developed a novel production process of Tamiflu bulk substance (oseltamivir phosphate) and succeeded in production of its samples.

The company said that its synthetic process started with not shikimic acid but the by-product from the fermentat...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.